The largest database of trusted experimental protocols

Caspase glo 3 7 reagent

Manufactured by Promega
Sourced in United States, United Kingdom

The Caspase-Glo 3/7 reagent is a luminescent assay that measures the activities of caspase-3 and caspase-7, two key enzymes involved in the apoptosis (programmed cell death) pathway. The reagent contains a proluminescent caspase-3/7 substrate, which is cleaved by the active enzymes, resulting in the generation of a luminescent signal. This signal is proportional to the amount of caspase-3/7 activity present in the sample.

Automatically generated - may contain errors

181 protocols using caspase glo 3 7 reagent

1

Caspase-3/7 Activity Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 96-well plates. On the next day, cells were treated with 100 µL Caspase-Glo® 3/7 Reagent (Promega, Madison, WI, USA) for 0.5–3 h at 25 °C. Then, caspase-3/7 activity was quantitated with a luminometer. Untreated cells were used as a negative control.
+ Open protocol
+ Expand
2

Measuring Neutrophil Apoptosis Induced by Terpenoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell apoptosis was analyzed by measuring the activity of proapoptotic caspases 3/7. Neutrophils (2 × 105 cells/well), suspended in solutions of FOH (trans,trans−3,7,11-Trimethyl−2,6,10-dodecatrien−1-ol; Sigma-Aldrich, St. Louis, MO, USA), FA (Echelon Biosciences Inc, Salt Lake City, UT, USA) or TR (Sigma-Aldrich, St. Louis, MO, USA) at variable concentrations, were placed in the wells of a 96-well white microplate and incubated for 1 h at 37 °C, at 5% CO2. Then, the cells were washed with PBS, and 100 µL of Caspase-Glo® 3/7 Reagent (Caspase-Glo® 3/7 Assay, Promega, Madison, WI, USA) was added to each well, the plate was gently mixed by shaking at 300 rpm for 30 s and the chemiluminescence was measured continuously for 2 h at 37 °C.
+ Open protocol
+ Expand
3

Evaluating Apoptosis in PDAC Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the apoptotic rate for PDAC cell lines, 5000 cells/well were seeded in white 96-well plates and cultured for 24 h with Pladienolide-B or vehicle, and apoptotic rates were measured using Caspase-Glo 3/7 Reagent (Promega), following the manufacturer’s instructions [36 (link)]. For Annexin-V staining, floating and attached cells were pooled and resuspended in 1X Annexin-V staining buffer containing Annexin-V-FITC diluted 1:20 (Cat no. 29001, Biotium, Freemont, CA) and then, incubated for 20 min at room temperature prior to flow cytometric analysis. Cytometry data was acquired with an Invitrogen™ Attune™ NxT 4-laser cytometer with software version 3.1.1.
+ Open protocol
+ Expand
4

Caspase 3/7 Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (5 × 103 cells/well) were seeded in a 96-well white plate and treated with MASM7, MFI8. Caspase 3/7 activation was measured after 6 h by addition of the Caspase-Glo 3/7 reagent according to the manufacturer’s protocol (Promega). Luminescence was detected by a F200 PRO microplate reader (TECAN). Caspase assays were performed in at least triplicate and the data normalized to vehicle-treated control wells. Dilutions of MASM7 or MFI8 were performed using a TECAN D300e Digital Dispenser from 10 mM stocks.
+ Open protocol
+ Expand
5

Caspase-Mediated Apoptosis Induction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 1

Caspase Activity assay: This is a cell assay to measure the induction of apoptosis in MOLP-8 (multiple myeloma), KMS-12-BM (multiple myeloma), MV4; 11 (acute myeloid leukemia), and NCI-H23 (non-small cell lung cancer) cells after 6 h treatment with Mcl-1 inhibitors. On the first day, 3000 (MOLP-8, KMS-12-BM, MV4; 11) or 1250 (NCI-H23) cells/well were seeded with 50 μL of growth media (IMDM+10% FBS+2 mM L-Glu for MV4; 11 and RPMI-1640+10% FBS+2 mM L-Glu for all others) in 384-well white microplates, and incubated overnight (37° C., 5% C02, 80% RH). On the second day, the cells were treated with Compound I using an ECHO acoustic liquid handler (10 point half-log serial dilution, 31.5 μM top concentration, 0.3% final DMSO concentration). After 6 h incubation (37° C., 5% C02, 80% RH), 25 μL of Caspase-Glo 3/7 reagent (Promega) was added into each well, and plates were incubated at room temperature for 30 min protected from light. Luminescence was recorded using an Infinite M200 microplate reader (Tecan) with a 100 ms integration time. EC50 values were calculated using GeneData analysis software and are shown in Table 2, below.

TABLE 2
Results from in vitro Caspase Activity assay
Compound I
Cell LineCaspase Activity, EC50 (nM)
MOLP-830
KMS-12-BM43
MV4; 1120
NCI-H23193

+ Open protocol
+ Expand
6

Spheroid Apoptosis Assay for PANC1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PANC1 cells were seeded 5000 cells/ml in SCM media in Ultra-Low attachment T75 flask (Corning # 3814), and allowed to grow 5 days to form spheres. The spheres were treated with compound for 20 h. Spheres were pelleted by centrifugation and cell apoptosis was measured by addition of 100 μl of Caspase-Glo 3/7 reagent (Promega) directly to the pellet, incubation at room temperature for 30 min, and then transfer of 30 μl per well to each of three wells in a 384-well plate, to measure the luminescence signal with a ViewLux reader.
+ Open protocol
+ Expand
7

Quantitative Analysis of Caspase Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For quantitative analysis of caspase activation, Caspase-Glo 3/7 Reagent (Promega) was added directly to Hepa1-6 cells in a 96- or 384-well plate at a volume equal to the sample volume. Luminescence was recorded after 30 min using a TECAN Infinite M200 plate reader. Background readings determined from wells containing culture medium only were subtracted. Relative caspase activity was calculated as 100% × luminescence reading of a treated sample/luminescence reading of a mock-treated control.
+ Open protocol
+ Expand
8

Evaluating Apoptosis Induction by NVS-ZP7-4

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess if NVS-ZP7-4 was stimulating the activity of caspase 3/7, an indicator of apoptosis, the Caspase-Glo 3/7 assay system (Promega, Fitchburg, WI) was used. Included in this assay were control compounds including Thapsigargin (Sigma), which is known to induce apoptosis, along with negative controls that included DMSO and NVS-ZP7-6 (inactive version of NVS-ZP7-4). The ARPE-19 was cultured, serum starved in 1% FBS overnight, then treated with IL-1 β (5ng/ml) alone or IL-1 β plus NVS-ZP7-4 (2 μM or 10 μM) for 24hr. Caspase-Glo 3/7 reagent (Promega) was prepared according to the manufacture’s protocol and added to the cells 24 h after compound addition. Each sample was incubated with the Caspase-Glo 3/7 reagent for 30 min and then luminescence (relative luminescence units) was read on the EnVision Multimode Plate Reader (PerkinElmer).
+ Open protocol
+ Expand
9

Caspase-3/7 Activity Assay in Lung Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 3–5×103 transfected HCC827 or Calu-3 cells were seeded in 96-well plates. After 48 h, cells were treated with Caspase-Glo® 3/7 reagent (Promega Corporation) according to the manufacturer's protocol; following agitation for 30 sec, cells were incubated for 2 h at room temperature. Fluorescence activity was analyzed using a GloMax® 96 Microplate Luminometer system (Promega Corporation). Relative fluorescent activity was quantified by setting the blank control to 1.
+ Open protocol
+ Expand
10

Caspase-3/7 Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Caspase-Glo 3/7 (Promega) was employed as a readout of inhibition where by a caspase-cleavable protected luciferase substrate is directly sensitive to caspase-3/7 activity and quantifiable by bioluminescence (28 (link)). Caspase inhibitor dissolved in DMSO (0, 0.1, 1, 10, 100, 1000, or 10000 nM) was combined with recombinant human caspase-3 enzyme (C1224-10UG, Sigma) (100 nM) in 1× phosphate buffered saline (PBS) in microcentrifuge tubes, vortexed, and incubated at 37°C for 30 min. After incubation, Caspase-Glo 3/7 reagent (Promega) was added in accordance with the manufacturer’s instructions. Solutions were vortexed, incubated for an additional 30 min, and dispensed into opaque wall/bottom 384-well plates (BD Biosciences) for measurement of caspase activity. Sample luminescence was measured using a Synergy 4 plate reader (BioTek).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!